Advances in high-throughput sequencing techniques and bioinformatic analysis have
refuted the “junk” RNA hypothesis that was claimed against non-coding RNAs (ncRNAs) …

Due to the high heterogeneity and initially asymptomatic nature of breast cancer (BC), the
management of this disease depends on imaging together with immunohistochemical and …

Breast cancer is a collation of malignancies that manifest in the mammary glands at the early
stages. Among breast cancer subtypes, triple-negative breast cancer (TNBC) shows the …

Circular RNAs (circRNAs) are novel noncoding RNAs with covalently closed-loop structures
that can regulate eukaryotic gene expression. Due to their stable structure, circRNAs are …

The concept of the 'BRCAness' phenotype implies the properties that some sporadic breast
cancers (BC) share with BRCA1/2-mutation carriers with hereditary BC. Breast tumors with …

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer, marked by poor outcomes and dismal prognosis. Due to the absence of targetable …

RNAs are versatile molecules that are primarily involved in gene regulation and can thus be
widely used to advance the fields of therapeutics and diagnostics. In particular, circular …

Implementing precision oncology for breast cancer (BC) is a critical method for improving
patient outcomes, which relies on the use of reliable biomarkers to be effective and safe …

Previous investigations have revealed that circular RNAs (circRNAs) play pivotal roles in
cancer development and progression by participating in several biological procedures, such …

Simple Summary Triple-negative breast cancer accounts for 15–20% of breast tumors. It is a
very aggressive and heterogeneous disease characterized by the absence of druggable …